Clinical trial

Intranasal Insulin in Parkinson's Disease

NCT04251585

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2020-02-04

PhasePHASE2

Study timeline

Study start (actual)2020-02-04Date precision: day

Registry last updated2026-02-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Parkinson Diseaseunresolved

Interventions

Regular Novolin RDRUG

PlaceboDRUG

Sponsors & collaborators

HealthPartners Institutelead sponsor

Mapped research locations

Saint PaulMinnesota, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04251585 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.